OTC Markets OTCPK - Delayed Quote USD
Abingdon Health Plc (ABDXF)
0.0700
0.0000
(0.00%)
At close: May 2 at 4:00:00 PM EDT
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
6,135
6,135
4,045
2,835
11,618
Cost of Revenue
2,456
2,456
1,970
6,427
7,475
Gross Profit
3,679
3,679
2,075
-3,592
4,143
Operating Expense
5,544
5,544
5,936
8,513
9,663
Operating Income
-1,865
-1,865
-3,861
-12,105
-5,520
Net Non Operating Interest Income Expense
-26
-26
14
-65
-234
Pretax Income
-1,399
-1,399
-3,574
-21,593
-6,954
Tax Provision
-128
-128
-105
-331
19
Net Income Common Stockholders
-1,271
-1,271
-3,469
-21,262
-6,973
Diluted NI Available to Com Stockholders
-1,271
-1,271
-3,469
-21,262
-6,973
Basic EPS
-0.01
-0.00
-0.01
-0.07
-0.03
Diluted EPS
-0.01
-0.00
-0.01
-0.07
-0.03
Basic Average Shares
304,033.6320
304,732.2640
304,033.3630
291,622.6380
263,709.8920
Diluted Average Shares
307,137.7340
308,201.2270
305,820.4200
291,622.6380
263,709.8920
Total Operating Income as Reported
-1,373
-1,373
-3,588
-21,528
-6,720
Rent Expense Supplemental
--
--
--
17
1
Total Expenses
8,000
8,000
7,906
14,940
17,138
Net Income from Continuing & Discontinued Operation
-1,271
-1,271
-3,469
-21,262
-6,973
Normalized Income
-1,482.6819
-1,482.6819
-3,491.3243
-11,129.8558
-5,920
Interest Income
31
31
89
4
--
Interest Expense
57
57
75
69
234
Net Interest Income
-26
-26
14
-65
-234
EBIT
-1,342
-1,342
-3,499
-21,524
-6,720
EBITDA
-916
-916
-2,725
-19,887
-5,971
Reconciled Cost of Revenue
2,456
2,456
1,970
6,427
7,475
Reconciled Depreciation
426
426
774
1,637
749
Net Income from Continuing Operation Net Minority Interest
-1,271
-1,271
-3,469
-21,262
-6,973
Total Unusual Items Excluding Goodwill
233
233
23
-9,515
-1,300
Total Unusual Items
233
233
23
-8,752
-1,300
Normalized EBITDA
-1,149
-1,149
-2,748
-11,135
-4,671
Tax Rate for Calcs
0.0001
0.0001
0
0
0.0002
Tax Effect of Unusual Items
21.3181
21.3181
0.6757
-145.8558
-247
6/30/2021 - 8/19/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
VOX.WA Voxel S.A.
146.80
-0.54%
LO3A.BE Lonza Group Ltd
64.00
-0.78%
TMOF.VI Thermo Fisher Scientific Inc.
372.75
-0.25%
ESF0.MU Eurofins Scientific SE
56.22
+1.08%
BIOPOR.CO BioPorto A/S
1.5900
+0.63%
SHL.AX Sonic Healthcare Limited
26.03
-0.12%
NOTV Inotiv, Inc.
2.0400
+0.49%
ERF.PA Eurofins Scientific SE
57.70
+1.98%
LONN.SW Lonza Group AG
598.00
-0.30%
ACRS Aclaris Therapeutics, Inc.
1.2800
-11.11%